Cancer Biomarkers

Journal Abbreviation: CANCER BIOMARK
Journal ISSN: 1574-0153

About Cancer Biomarkers

    Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion. The disease markers may include, but are not limited to, genomic, epigenomic, proteomics, cellular and morphologic, and genetic factors predisposing to the disease or indicating the occurrence of the disease. Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation will be accepted.
Year Impact Factor (IF) Total Articles Total Cites
2022 (2023 update) 3.1 - 3701
2021 3.828 - 4022
2020 4.388 157 3841
2019 3.436 145 2842
2018 2.859 249 1963
2017 2.392 182 1354
2016 2.274 129 1019
2015 1.736 103 783
2014 1.721 54 682
2013 1.186 56 557
2012 0.972 39 411
2011 1.078 49 306
2010 2.418 44 327